Home
About
Overview
Sharing Data
ORCID
Help
History (3)
5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation.
Principal Investigator
YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.
YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. Mol Cancer. 2019 11 18; 18(1):163.
View in:
PubMed
subject areas
Adenosine
Animals
Carcinoma, Hepatocellular
Epigenesis, Genetic
Humans
Inflammation
Liver Neoplasms
Methylation
Mice
Models, Biological
Neovascularization, Pathologic
RNA, Messenger
RNA-Binding Proteins
Transcriptome
authors with profiles
Chuan He